Alto Neuroscience, Inc. Common Stock (ANRO)
R&D Expense Growth
8.94%
Quarterly · Period ending:
ANRO R&D Expense Growth
Latest reported8.94%period ending
Latest reported8.94%period ending
ANRO Quarterly R&D Growth (QoQ) (0.00% → 8.94%)
Latest values, visible window
High-resolution chart · PNG
ANRO r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 8.9386% | |
| 69.1731% | |
| 13.9762% | |
| -19.8034% | |
| 31.5821% | |
| -7.6481% | |
| -17.3047% | |
| -0.9405% | |
| 32.4759% | |
| 3.2044% | |
| 21.0368% | |
| 12.6555% | |
| 26.0831% | |
| -11.3061% | |
| 0% |